NEWS

   

EVENTS

Conferences

BIO Executive Training Programs

BIO EXECUTIVE TRAINING PROGRAMS

May 31-02, 2019
BIO’s Executive Training Programs provide instruction in the functional skills necessary to address fundamental challenges that biotech entrepreneurs, business development executives, reimbursement professionals, and people new to the biotech industry face as they seek to excel in their career...

2019 BIO International Convention

2019 BIO INTERNATIONAL CONVENTION

June 03-06, 2019
Join us in Philadelphia, PA, June 3-6, 2019 as more than 16,000 attendees from around the globe gather for unparalleled partnering, education, networking, and to see all that tri-state area has to offer. The region's vast array of leading universities and research institutions fosters a collabor...

BIO 2019

BIO 2019

June 03-06, 2019
The key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry thought-leaders with over 500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendee...

3rd International Cancer Conference and Expo

3RD INTERNATIONAL CANCER CONFERENCE AND EXPO

June 05-07, 2019
With the enthusiastic support of our Organizing Committee, we invite you to participate in the 3rd International Cancer Conference and Expo which is being held as a continuum of our previous successful conference in Philadelphia, USA. 3rd International Cancer Conference and Expo (iCancer 2019) welco...

2nd International Microfluidics Congress

2ND INTERNATIONAL MICROFLUIDICS CONGRESS

May 23-24, 2019
This conference will bring together engineers, scientists, and practitioners to showcase the newest developments and discuss future directions in microfluidic technologies and their applications in complex systems, broadly defined. The topics will be wide-ranging, including chemical synthesis, separ...

Reproductive Medicine & Biology

REPRODUCTIVE MEDICINE & BIOLOGY

May 23-24, 2019
Reproductive Biology Conference is delighted to welcome the participants from all over the world to attend the prestigious International Conference on Reproductive Medicine & Biology(ICRMB19). The conference provides global coliseum to international scholars and researchers to voice their resear...

NDD Europe

NDD EUROPE

May 21-23, 2019
NDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration, improving preclinical modeling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug develope...

9th Global Summit on Neuroscience and Neuroimmunology

9TH GLOBAL SUMMIT ON NEUROSCIENCE AND NEUROIMMUNOLOGY

May 22-23, 2019
Neuroimmunology 2019 is an elite stage to unite overall eminent researchers in the field of Neuroscience, Neuroimmunology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The...

 

Webinars

MAY 28, 2019 | 3:00 AM
NEW DRUG PRODUCT DEVELOPMENT USING CONTINUOUS MANUFACTURING
What is Drug Product Continuous Manufacturing? Is Continuous Manufacturing really worth the effort? "without data, you are just another person with an opinion" What are the challenges implementing CM? Development and tech transfer considerations for CM. Learning Objectives: Demon...
MAY 28, 2019
STRENGTHENING NEUROSCIENCE CLINICAL RESEARCH THROUGH INNOVATION
There’s a lot of discussions these days about innovative ideas to make clinical research more patient-focused. The concept goes hand-in-hand with the development of technology that permits researchers to design and execute trials that can significantly reduce the burden of participat...
MAY 29, 2019
IMPLEMENTATION OF AN AFFORDABLE AND SCALABLE MANUFACTURING STRATEGY FOR GENE THERAPY PRODUCTS
As a start up with multiple clinical programs within an accelerated track we started designing our processes and aimed to build facilities to ensure therapeutic drug products reach patients as quickly as possible. This tends to be the main goal for scientists and patients. Because there ar...
MAY 30, 2019 | 9.00 AM
LABORATORY TESTING & AUTOMATION 2019
Welcome to the 3rd Annual Laboratory Testing & Automation Virtual Event; a free virtual conference for professionals interested in the most recent technologies for today’s labs. Lab automation is a multi-disciplinary approach benefiting from technologies in the lab that facilitat...
JUN 05, 2019
DIMENSION OF TIME: FROM CULTURE TO ASSAY
This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells. Start at the beginning and learn more about the cell health, growth and morphology of your cells in culture.  From there, gain a better understanding of the efficienc...
JUN 05, 2019 | 4:00pm
BIOMARKERS IN DRUG DISCOVERY AND DEVELOPMENT
High development costs and low success rates in bringing new medicines to the market demand more efficient and effective approaches. The FDA supports model-based drug discovery and development. This represents a mathematical and statistical approach that constructs, validates, and utilizes...

PLANTS WITH SUPERPOWERS (GMO) WEBINAR
Sponsored
We’ve all seen non-GMO labels in the grocery store. What does GMO mean and why should we care? In this webinar, Biology Fortified will show how biotechnology can be used to give plants superpowers. We will discuss plant breeding methods, current and future GMO traits, GMO safety, and...
DNA METHYLATION CHANGES DURING CELL DIFFERENTIATION WEBINAR
Sponsored
Listen in as Dr Ballestar discusses an overall perspective on the connections between DNA methylation and other epigenetic marks, as well as the interplay with transcription factors.
THE POTENTIAL OF ENGINEERED HUMAN LIVER CO-CULTURES IN PHENOTYPIC DRUG DISCOVERY FOR LIVER DISEASES
The diverse functions of the liver (i.e. albumin synthesis, glucose and fatty acid metabolism, drug metabolism) can be severely compromised by several diseases. In particular, drug-induced liver injury is a leading cause of drug attrition; hepatitis B virus chronically infects the livers o...
COMBINING TRANSPORTER DATA WITH QUANTITATIVE SYSTEMS TOXICOLOGY MODELING (DILISYM) TO IMPACT DECISIONS IN DRUG DEVELOPMENT
A quantitative systems toxicology (QST) model of drug-induced liver injury (DILI) has been developed through the DILI-sim Initiative over the past 7 years to assist in the safety characterization of compounds in clinical development.  The emerging platform, DILIsym®, is capable of...
THE UTILITY OF MICROSCALE HUMAN LIVER CO-CULTURES FOR INVESTIGATING DRUG TOXICITY OUTCOMES
Drug-induced liver injury (DILI) remains a leading cause of acute liver failures and the attrition of pharmaceuticals in both preclinical and clinical settings. Due to species-specific differences in drug metabolism pathways, animal models do not always fully predict human DILI. Thus, ther...
ENGINEERING MICROPATTERNED CO-CULTURES FOR DRUG DEVELOPMENT
Due to significant differences across species in liver pathways, models of the human liver are used to screen for potential efficacy and/or toxicity of candidate compounds. Such models serve to complement and reduce the number of animals used in studies required by regulatory agencies. How...

RESOURCES

The pharmaceutical and medical industry suffers huge pain, high cost and poor results from conventional biological indicators. This new science of using Enzyme Indicators for measuring decontamination...

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with d...

No other problem in cell culturing is as universal as microbial contamination. In order to avoidit, good sterile techniques and thorough culture handling are essential. Beyond that, the CO2 incubator ...

New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient methods are requ...

During the cultivation of animal cells the monitoring of nutrients and metabolites has an important role for the controlling strategy of the cell culture. The measurement of glucose and lactate is one...

Design of experiments (DoE) is one of the most important techniques for systematic planning, execution and statistical evaluation of experiments. Although a DoE investigation is executable in one bior...

The development of biosimilars requires extensive physicochemical characterization of biosimilar candidate molecules which should match the quality profile of the reference molecule (originator). Here...

The presented data demonstrates that chemical denaturation is a feasible approach to predict the colloidal long-term stability of biologicals. Moreover, changes in G in dependence of the protein con...

It is the nirvana that Life Sciences organizations have been chasing for the past 30 years. The time is finally now. A digital transformation is taking place in the life sciences industry, from resear...